MedTrace Logo

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

NCT05044689 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-03-21

No results posted yet for this study

Summary

This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.

Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaire containing questions regarding diet, physical activity, past medical history and life style practices.

DEVICE

Bioimpedance/Body Composition Unit

Patients will provide information on body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water.

Sponsors & Collaborators

  • Memorial Sloan Kettering Cancer Center

    collaborator OTHER

  • Lagos State University

    collaborator OTHER

  • University of Ilorin Teaching Hospital

    collaborator OTHER

  • Federal Medical Centre, Owo

    collaborator INDUSTRY

  • University of Maiduguri Teaching Hospital

    collaborator UNKNOWN

  • National Hospital, Abuja

    collaborator OTHER_GOV

  • Obafemi Awolowo University Teaching Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05044689 on ClinicalTrials.gov